Nakanishi, Kaoru

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy

Sato, T., Nagai, M., Watanabe, O., Misu, T., Takenouchi, N., Ohkubo, R., Ishihara, S., Tsuboi, Y., Katsuno, M., Nakagawa, M., et al. (2024) · Journal of Neurology

T-cell and Retrovirus StudiesInfectious Diseases and Tuberculosis

Cited by 21